A peripheral blood smear revealed vacuolated myeloid precursors, and targeted genetic testing identified a somatic pathogenic variant in the UBA1 gene (p.Met41Val), confirming the diagnosis of VEXAS syndrome. The gene discussed is UBA1; the disease is VEXAS syndrome.